Evidence-based·Last reviewed May 30, 2026·How we grade evidence

Ginkgo

BotanicalBilobalide

Useful mainly for older adults with existing mild cognitive impairment or peripheral artery walking pain, using a standardized extract.

Quick decision guide

May help most

Older adults with existing mild cognitive impairment or peripheral artery walking pain, using a standardized extract

Common dosing range

120–240 mg/day standardized extract, split

When to expect effects

Weeks (4–6 weeks to plateau)

Watch out for

Increased bleeding risk, especially with anticoagulant or antiplatelet drugs

What is it

Ginkgo (Ginkgo biloba) is a unique tree species native to China, with a fossil record dating back over 200 million years. Its fan-shaped leaves are used in herbal medicine, primarily as standardized extracts containing flavone glycosides (typically 24 percent) and terpene lactones (typically 6 percent).

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if

You have diagnosed mild cognitive impairment or early dementia and want a low-risk adjunct
You have intermittent claudication and want a modest add-on to exercise
You can use a standardized EGb 761-type extract and commit to 6+ weeks

Probably skip if

You are a healthy adult hoping to boost normal memory
You take warfarin, a DOAC, or antiplatelet drugs
You have a seizure disorder or surgery scheduled within 2 weeks
You want a fast or dramatic effect

Evidence at a glance

dementia and mild cognitive impairment

Limited Evidence
Effect
Modest, inconsistent
Best fit
Older adults with existing mild cognitive impairment or early Alzheimer's using EGb 761 at ~240 mg/day
Time
Weeks to months

intermittent claudication

Limited Evidence
Effect
Small increase in walking distance
Best fit
People with peripheral artery disease and exertional leg pain
Time
Weeks

vertigo and dizziness

Limited Evidence
Effect
Modest
Best fit
Adults with vestibular vertigo
Time
Weeks

cognitive function in healthy adults

Mixed Evidence
Effect
None reliably demonstrated
Best fit
No clearly benefiting healthy group identified
Time
Not established

tinnitus

Mixed Evidence
Effect
Small, inconsistent
Best fit
Adults with tinnitus, possibly those whose tinnitus accompanies cognitive decline
Time
Weeks

Evidence for 5 uses

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

dementia and mild cognitive impairment

Disease adjunct
Limited Evidence

Smaller trials of the standardized extract EGb 761 at 240 mg/day report modest improvement in patients with existing mild cognitive impairment or early Alzheimer's. The large GEM trial (3,069 older adults over 6 years) found no reduction in dementia incidence, and the Cochrane review judged the overall evidence inconsistent and unreliable.

Effect size
Modest, inconsistent
Time to effect
Weeks to months
Best fit
Older adults with existing mild cognitive impairment or early Alzheimer's using EGb 761 at ~240 mg/day
Less likely
Healthy adults using it to prevent dementia

Bottom line: A modest, unreliable adjunct in established cognitive impairment, not a prevention strategy.

Evidence is mixed

Small symptomatic trials are positive while the largest prevention trial and Cochrane review are negative, so the picture is genuinely mixed.

intermittent claudication

Disease adjunct
Limited Evidence

Trials and meta-analyses of ginkgo in intermittent claudication show a small increase in pain-free walking distance versus placebo. The effect is modest and supervised exercise remains first-line.

Effect size
Small increase in walking distance
Time to effect
Weeks
Best fit
People with peripheral artery disease and exertional leg pain

Bottom line: A modest add-on for claudication walking distance, not a substitute for exercise therapy.

vertigo and dizziness

Supplement benefit
Limited Evidence

A few controlled trials report that standardized ginkgo extract reduces vertigo symptom frequency and intensity, in some comparisons performing similarly to betahistine. Evidence is limited in size and quantity.

Effect size
Modest
Time to effect
Weeks
Best fit
Adults with vestibular vertigo

Bottom line: Limited evidence suggests modest help for vertigo symptoms.

cognitive function in healthy adults

Supplement benefit
Mixed Evidence

Controlled trials in cognitively healthy adults have not shown consistent improvement in memory or attention. Positive findings are small, short, and not reproduced in larger studies.

Effect size
None reliably demonstrated
Time to effect
Not established
Best fit
No clearly benefiting healthy group identified

Bottom line: No reliable cognitive boost in healthy people.

tinnitus

Supplement benefit
Mixed Evidence

Evidence for ginkgo in tinnitus is mixed: some trials report modest reductions in perceived loudness or distress while others show no benefit over placebo. Any effect is small.

Effect size
Small, inconsistent
Time to effect
Weeks
Best fit
Adults with tinnitus, possibly those whose tinnitus accompanies cognitive decline

Bottom line: Worth a time-limited trial for bothersome tinnitus, but results are unreliable.

Evidence is mixed

Trial results conflict, with several showing no separation from placebo.

How it works

Ginkgo's main proposed effects involve cerebral blood flow, platelet activity, and antioxidant function. Flavone glycosides and terpene lactones (including ginkgolide B) appear to inhibit platelet-activating factor (PAF), modestly improve microcirculation, and scavenge free radicals. Improved cerebral perfusion is the popular mechanistic story for ginkgo's traditional reputation in cognition and dementia. Clinical evidence has been mixed. The Ginkgo Evaluation of Memory (GEM) trial, the largest controlled study (3,069 older adults followed for 6 years), found no significant effect on incidence of dementia. Smaller and shorter trials in patients with existing mild cognitive impairment or early Alzheimer's have shown modest benefits with the standardized extract EGb 761 at 240 mg per day. The Cochrane review on ginkgo for dementia concluded the evidence is inconsistent and unreliable. Ginkgo also has more consistent evidence for tinnitus (mixed results) and intermittent claudication (modest improvement in walking distance).

How to take it

1. Typical dose
120–240 mg/day standardized extract (24% flavone glycosides, 6% terpene lactones)
2. Timing
Morning and midday, with or without food
3. With food
With or without food
4. Split dosing
Divided into 2–3 doses
5. How long to try
Trial at least 6 weeks before judging cognitive or circulation benefit

What to track

Memory or daily cognitive function
Pain-free walking distance
Tinnitus loudness
Any bruising or bleeding

3 commercial forms

Compare the main delivery options and what they’re best suited for.

EGb 761 (standardized ginkgo extract)

The reference standardized extract. Tebonin and Tanakan are common brand names internationally.

Standardized to 24 percent flavone glycosides and 6 percent terpene lactones; the form used in most positive trials.

Generic standardized ginkgo (24/6)

Most consumer products. Look for the 24/6 standardization marker and certifications for quality.

Matches EGb 761 specification; quality varies by manufacturer.

Whole leaf ginkgo (unstandardized)

Less reliable and potentially more allergenic. Standardized extracts are preferred.

Variable bioactive content; may contain higher ginkgolic acid levels.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

Mild GI upsetHeadacheDizzinessRash

Serious risks

Who should avoid it

Pregnancy & breastfeeding

Avoid in pregnancy and breastfeeding due to limited safety data and bleeding concerns.

Interactions

Warfarin and other anticoagulantsMajor

Additive bleeding risk; case reports of serious hemorrhage

Aspirin, clopidogrel, NSAIDs (antiplatelets)Major

Additive bleeding risk via platelet-activating factor inhibition

Anticonvulsants (carbamazepine, phenytoin, valproate)Moderate

May lower drug levels and reduce seizure control

Diabetes medicationsModerate

May lower blood sugar, compounding hypoglycemia risk

CYP3A4/CYP2C19-metabolized drugsModerate

Ginkgo can alter levels of drugs cleared by these enzymes

Documented interactions

Evidence-graded pair pages with sources, dosing notes, and timing guidance — a complement to the narrative section above.

See all 7 Ginkgo interactions

Choosing a product

What to look for on the label — and what to be skeptical of.

Look for

Standardized to 24% flavone glycosides and 6% terpene lactones
EGb 761 or equivalent named extract
Ginkgolic acids limited to under 5 ppm

Be skeptical of

Boosts memory in healthy people
Prevents Alzheimer's or dementia
Improves overall brain power

Frequently asked questions

Will ginkgo improve my memory?

In healthy adults with normal cognition, controlled trials generally find no significant memory improvement. In adults with mild cognitive impairment or early dementia, smaller trials have shown modest benefits, but the largest long-term trial (GEM) found no effect on dementia incidence.

Is ginkgo safe to take with aspirin or fish oil?

Caution is warranted. Both ginkgo and aspirin have antiplatelet effects, and case reports describe intracranial bleeding with the combination. Fish oil at high doses adds further antiplatelet effect. If you are on any anticoagulant or antiplatelet regimen, discuss with your prescriber.

How long until ginkgo works?

Effects build over 4 to 6 weeks of consistent daily use. Don't expect acute effects from a single dose. If you don't see meaningful improvement after 12 weeks at 240 mg/day, it likely isn't going to.

Can I eat ginkgo nuts?

Cooked ginkgo seeds are eaten in some Asian cuisines but should be limited to small amounts (a few seeds per day) because they contain 4-O-methylpyridoxine, which can cause seizures at higher amounts. Raw seeds are more dangerous. Ginkgo supplements use leaf extract, not seed.

Does ginkgo really help with tinnitus?

Trial results are mixed. Some show modest improvement, others show no effect. If you try it, give it 12 weeks at 120 to 240 mg/day before judging. Many users find it doesn't help dramatically, but it has a clean safety profile if you have no bleeding concerns.

References by claim

dementia and mild cognitive impairment

Tan et al., 2015PubMed (2015) link

Riepe et al., 2025PubMed (2025) link

cognitive function in healthy adults

Laws et al., 2012PubMed (2012) link

Tiemtad et al., 2026PubMed (2026) link

intermittent claudication

Pittler et al., 2000PubMed (2000) link

Nicolaï et al., 2013PMC (2013) link

tinnitus

Rejali et al., 2004PubMed (2004) link

Hilton et al., 2013PMC (2013) link

vertigo and dizziness

Sha et al., 2022PMC (2022) link

Jianbunjongkit et al., 2026PMC (2026) link

Safety

Memorial Sloan Kettering — GinkgoMSKCC About Herbs link

Track Ginkgo with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store
Evidence-based·Last reviewed May 30, 2026·Evidence current as of May 30, 2026·How we grade evidence

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.